Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 14Breast Neoplasms 12Multiple Myeloma 8Neoplasm Metastasis 5Pain 4Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Renal Insufficiency 1Pleural Effusion, Malignant 1Osteoporosis 1Osteonecrosis 1Osteolysis 1Neoplastic Cells, Circulating 1Lung Neoplasms 1Lung Metastases 1Carcinoma, Renal Cell 1Bone Neoplasms 1Bone Diseases, Metabolic 1

Interventions

Zoledronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Lung Metastases × Zoledronic Acid × Clear all
NCT03932071 2019-05-06

Zoledronic Acid in Decrease the Lung Metastatic Rate of Osteosarcoma

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 4 Unknown
150 enrolled

Lung Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡